Where can I read MDT's latest 10-K?

MDT's latest annual report, a 10-K, was filed on Jun 18, 2026 for the fiscal year ended Apr 24, 2026. It is linked above and opens on EDGAR, the SEC's own site, where every exhibit is also listed.

When did MDT last file an 8-K?

On Sep 17, 2026 it covered other events. An 8-K reports a material event between quarterly reports; the one that furnishes the quarter's results is filed under Item 2.02, last on Sep 1, 2026.

Are MDT insiders buying or selling?

Over the last 13 months insiders sold $5.9M in 4 sales and bought nothing on the open market; 77 other transactions (awards, exercises, tax withholding, gifts and plan purchases). The most recent sale: KIIL HARRY SKIP (EVP & President Cardiovascular) sold 1,483 shares on Sep 16, 2026 for $139K. Every figure is as the insider filed it on Form 4; a sale under a 10b5-1 plan was scheduled in advance.

How many SEC filings has MDT made?

3,024 filings are on EDGAR under the registrant records that have been Medtronic plc., going back to 1994; 1,780 of them are insider ownership forms (Forms 3, 4, 5 and 144).

Share this page

MDT

$85.51-1.81%

as of close, Oct 7, 2026

☾ AH $85.51 -1.81%

Medtronic plc.Stock · HealthcareS&P 500 Equal Weight 0.2%S&P 500 0.2%US Stock Market 0.1%Russell 3000 0.1%

PeersMRNALLYUNHJNJMRKTMO

MDT SEC filings (2026)

CIK 1613103 · Electromedical & Electrotherapeutic Apparatus (SIC 3845) · fiscal year ends in April

3,024 filings on EDGAR since 1994 · 43 annual, 104 quarterly, 332 current · financial statements · earnings

Latest 10-K

Jun 18, 2026

fiscal year to Apr 24, 2026

Latest 10-Q

Sep 3, 2026

quarter to Jul 31, 2026

Latest 8-K

Sep 17, 2026

Other events

Last earnings release

Sep 1, 2026

$1.45 vs $1.39 · ▲ 1.5%

Filings on file

3,024

since 1994, 1,780 insider forms

What happened, last 12 months#

Every earnings release with its print, every report with its quarter, the other 8-Ks by the headline of the press release they furnish or by their items, the proxy statements, and each day an insider bought or sold — newest first, each line opening the filing on EDGAR. The index by form and year follows.

Insider transactions#

What officers, directors and 10% holders reported on Forms 4 and 5 over the last 13 months, from the documents themselves: one insider’s trades of one kind on one day are one row, with the shares, the price range and the total as filed. Open-market buys and sells first; awards, exercises, tax withholding, gifts and employee-plan purchases are grouped below them.

Over the last 13 months insiders sold $5.9M in 4 sales and bought nothing on the open market; 77 other transactions (awards, exercises, tax withholding, gifts and plan purchases).

Date	Insider	Action	Shares	Price	Value	Held after	Filing
Sep 16, 2026Form 4	KIIL HARRY SKIPEVP & President CardiovascularSold · $139K · 1,483 sh	Sold	1,483	$93.65	$139K	42,186	Form 4
Jul 8, 2026Form 4	Walter Matthew R.SVP, Chief HR OfficerSold · $258K · 3,102 sh · 10b5-1	Sold· 10b5-1 plan	3,102	$83.15	$258K	35,694	Form 4
Jun 8, 2026Form 4	KIIL HARRY SKIPEVP & President CardiovascularSold · $337K · 4,189 sh	Sold	4,189	$80.44–$80.45	$337K	37,227	Form 4
Feb 19, 2026Form 4	KIIL HARRY SKIPEVP & President CardiovascularSold · $5.1M · 52,524 sh	Sold	52,524	$97.66–$97.86	$5.1M	32,768	Form 4

Awards, exercises, withholding and plan purchases · 77 transactions

Date	Insider	Action	Shares	Price	Value	Held after	Filing
Sep 15, 2026Form 4	Blomquist Denise L.Chief Accounting OfficerGift · $0 · 600 sh	Gift	600	$0.00	$0	16,398	Form 4
Aug 20, 2026Form 4	Marinaro MichaelEVP, Pres MedSurg and AmericasTax withholding · $100K · 1,084 sh	Tax withholding	1,084	$92.30	$100K	116,336	Form 4
Aug 3, 2026Form 4	Martha GeoffreyChairman and CEO · DirectorAward · Stock Option (Right to Buy) · $0 · 568,152 sh	Award· Stock Option (Right to Buy)	568,152	$0.00	$0	273,150	Form 4
Aug 3, 2026Form 4	Martha GeoffreyChairman and CEO · DirectorAward · Performance Share Units · $0 · 103,831 sh	Award· Performance Share Units	103,831	$0.00	$0	103,831	Form 4
Aug 3, 2026Form 4	Pieton ThierryEVP & Chief Financial OfficerAward · Stock Option (Right to Buy) · $0 · 81,945 sh	Award· Stock Option (Right to Buy)	81,945	$0.00	$0	81,945	Form 4
Aug 3, 2026Form 4	Marinaro MichaelEVP, Pres MedSurg and AmericasAward · Stock Option (Right to Buy) · $0 · 77,848 sh	Award· Stock Option (Right to Buy)	77,848	$0.00	$0	77,848	Form 4
Aug 3, 2026Form 4	KIIL HARRY SKIPEVP & President CardiovascularAward · Stock Option (Right to Buy) · $0 · 65,556 sh	Award· Stock Option (Right to Buy)	65,556	$0.00	$0	65,556	Form 4
Aug 3, 2026Form 4	Marinaro MichaelEVP, Pres MedSurg and AmericasAward · $0 · 57,107 sh	Award	57,107	$0.00	$0	117,420	Form 4
Aug 3, 2026Form 4	Thompson KweliEVP & President, NeuroscienceAward · Stock Option (Right to Buy) · $0 · 49,167 sh	Award· Stock Option (Right to Buy)	49,167	$0.00	$0	49,167	Form 4
Aug 3, 2026Form 4	Quinn MichelleEVP, GC and SecretaryAward · Stock Option (Right to Buy) · $0 · 45,070 sh	Award· Stock Option (Right to Buy)	45,070	$0.00	$0	45,070	Form 4
Aug 3, 2026Form 4	Martha GeoffreyChairman and CEO · DirectorAward · $0 · 41,533 sh	Award	41,533	$0.00	$0	327,866	Form 4
Aug 3, 2026Form 4	Walter Matthew R.SVP, Chief HR OfficerAward · Stock Option (Right to Buy) · $0 · 40,973 sh	Award· Stock Option (Right to Buy)	40,973	$0.00	$0	40,973	Form 4
Aug 3, 2026Form 4	Pieton ThierryEVP & Chief Financial OfficerAward · Performance Share Units · $0 · 28,842 sh	Award· Performance Share Units	28,842	$0.00	$0	28,842	Form 4
Aug 3, 2026Form 4	Marinaro MichaelEVP, Pres MedSurg and AmericasAward · Performance Share Units · $0 · 27,400 sh	Award· Performance Share Units	27,400	$0.00	$0	27,400	Form 4
Aug 3, 2026Form 4	KIIL HARRY SKIPEVP & President CardiovascularAward · Performance Share Units · $0 · 23,074 sh	Award· Performance Share Units	23,074	$0.00	$0	23,074	Form 4
Aug 3, 2026Form 4	Thompson KweliEVP & President, NeuroscienceAward · Performance Share Units · $0 · 17,306 sh	Award· Performance Share Units	17,306	$0.00	$0	17,306	Form 4
Aug 3, 2026Form 4	Quinn MichelleEVP, GC and SecretaryAward · Performance Share Units · $0 · 15,863 sh	Award· Performance Share Units	15,863	$0.00	$0	15,863	Form 4
Aug 3, 2026Form 4	Walter Matthew R.SVP, Chief HR OfficerAward · Performance Share Units · $0 · 14,421 sh	Award· Performance Share Units	14,421	$0.00	$0	14,421	Form 4
Aug 3, 2026Form 4	Pieton ThierryEVP & Chief Financial OfficerAward · $0 · 11,537 sh	Award	11,537	$0.00	$0	49,645	Form 4
Aug 3, 2026Form 4	KIIL HARRY SKIPEVP & President CardiovascularAward · $0 · 9,230 sh	Award	9,230	$0.00	$0	43,669	Form 4
Aug 3, 2026Form 4	Thompson KweliEVP & President, NeuroscienceAward · $0 · 6,923 sh	Award	6,923	$0.00	$0	35,390	Form 4
Aug 3, 2026Form 4	Quinn MichelleEVP, GC and SecretaryAward · $0 · 6,346 sh	Award	6,346	$0.00	$0	26,721	Form 4
Aug 3, 2026Form 4	Walter Matthew R.SVP, Chief HR OfficerAward · $0 · 5,769 sh	Award	5,769	$0.00	$0	39,928	Form 4
Aug 3, 2026Form 4	Blomquist Denise L.Chief Accounting OfficerAward · $0 · 2,337 sh	Award	2,337	$0.00	$0	16,998	Form 4
Aug 3, 2026Form 4	Blomquist Denise L.Chief Accounting OfficerAward · Performance Share Units · $0 · 2,337 sh	Award· Performance Share Units	2,337	$0.00	$0	2,337	Form 4
Aug 3, 2026Form 4	Blomquist Denise L.Chief Accounting OfficerAward · Stock Option (Right to Buy) · $0 · 1,366 sh	Award· Stock Option (Right to Buy)	1,366	$0.00	$0	1,366	Form 4
Jul 31, 2026Form 4	Martha GeoffreyChairman and CEO · DirectorTax withholding · $1.4M · 15,810 sh	Tax withholding	15,810	$85.39	$1.4M	286,333	Form 4
Jul 31, 2026Form 4	Marinaro MichaelEVP, Pres MedSurg and AmericasTax withholding · $287K · 3,356 sh	Tax withholding	3,356	$85.39	$287K	60,313	Form 4
Jul 31, 2026Form 4	KIIL HARRY SKIPEVP & President CardiovascularTax withholding · $262K · 3,074 sh	Tax withholding	3,074	$85.39	$262K	34,439	Form 4
Jul 31, 2026Form 4	Thompson KweliEVP & President, NeuroscienceTax withholding · $148K · 1,739 sh	Tax withholding	1,739	$85.39	$148K	28,467	Form 4
Jul 31, 2026Form 4	Walter Matthew R.SVP, Chief HR OfficerTax withholding · $143K · 1,675 sh	Tax withholding	1,675	$85.39	$143K	34,159	Form 4
Jul 31, 2026Form 4	Blomquist Denise L.Chief Accounting OfficerTax withholding · $18K · 212 sh	Tax withholding	212	$85.39	$18K	14,661	Form 4
Jul 28, 2026Form 4	Quinn MichelleEVP, GC and SecretaryTax withholding · $180K · 2,069 sh	Tax withholding	2,069	$86.88	$180K	20,375	Form 4
Jun 5, 2026Form 4	Blomquist Denise L.Chief Accounting OfficerTax withholding · $20K · 237 sh	Tax withholding	237	$83.32	$20K	14,737	Form 4
Jun 4, 2026Form 4	Martha GeoffreyChairman and CEO · DirectorTax withholding · $3.5M · 41,936 sh	Tax withholding	41,936	$83.32	$3.5M	301,163	Form 4
Jun 4, 2026Form 4	Marinaro MichaelEVP, Pres MedSurg and AmericasTax withholding · $622K · 7,471 sh	Tax withholding	7,471	$83.32	$622K	63,122	Form 4
Jun 4, 2026Form 4	KIIL HARRY SKIPEVP & President CardiovascularTax withholding · $568K · 6,817 sh	Tax withholding	6,817	$83.32	$568K	41,416	Form 4
Jun 4, 2026Form 4	Walter Matthew R.SVP, Chief HR OfficerTax withholding · $237K · 2,840 sh	Tax withholding	2,840	$83.32	$237K	38,689	Form 4
May 26, 2026Form 4	Martha GeoffreyChairman and CEO · DirectorExercise or conversion · $0 · 94,963 sh	Exercise or conversion	94,963	$0.00	$0	343,099	Form 4
May 26, 2026Form 4	Martha GeoffreyChairman and CEO · DirectorExercise or conversion · Performance Share Unit · $0 · 85,461 sh	Exercise or conversion· Performance Share Unit	85,461	$0.00	$0	0	Form 4
May 26, 2026Form 4	Wall Brett A.EVP & Pres NeuroscienceExercise or conversion · $0 · 26,907 sh	Exercise or conversion	26,907	$0.00	$0	82,183	Form 4
May 26, 2026Form 4	Wall Brett A.EVP & Pres NeuroscienceExercise or conversion · Performance Share Unit · $0 · 24,214 sh	Exercise or conversion· Performance Share Unit	24,214	$0.00	$0	0	Form 4
May 26, 2026Form 4	Marinaro MichaelEVP, Pres MedSurg and AmericasExercise or conversion · $0 · 18,994 sh	Exercise or conversion	18,994	$0.00	$0	70,593	Form 4
May 26, 2026Form 4	Marinaro MichaelEVP, Pres MedSurg and AmericasExercise or conversion · Performance Share Unit · $0 · 17,093 sh	Exercise or conversion· Performance Share Unit	17,093	$0.00	$0	0	Form 4
May 26, 2026Form 4	KIIL HARRY SKIPEVP & President CardiovascularExercise or conversion · $0 · 15,195 sh	Exercise or conversion	15,195	$0.00	$0	48,233	Form 4
May 26, 2026Form 4	KIIL HARRY SKIPEVP & President CardiovascularExercise or conversion · Performance Share Unit · $0 · 14,517 sh	Exercise or conversion· Performance Share Unit	14,517	$0.00	$0	0	Form 4
May 26, 2026Form 4	Walter Matthew R.SVP, Chief HR OfficerExercise or conversion · $0 · 9,149 sh	Exercise or conversion	9,149	$0.00	$0	41,529	Form 4
May 26, 2026Form 4	Walter Matthew R.SVP, Chief HR OfficerExercise or conversion · Performance Share Unit · $0 · 8,449 sh	Exercise or conversion· Performance Share Unit	8,449	$0.00	$0	0	Form 4
May 26, 2026Form 4	Blomquist Denise L.Chief Accounting OfficerExercise or conversion · $0 · 1,712 sh	Exercise or conversion	1,712	$0.00	$0	14,974	Form 4
May 26, 2026Form 4	Blomquist Denise L.Chief Accounting OfficerExercise or conversion · Performance Share Unit · $0 · 1,621 sh	Exercise or conversion· Performance Share Unit	1,621	$0.00	$0	0	Form 4
May 1, 2026Form 4	Walter Matthew R.SVP, Chief HR OfficerTax withholding · $2,800 · 35 sh	Tax withholding	35	$80.00	$2,800	32,380	Form 4
Apr 28, 2026Form 4	Blomquist Denise L.Chief Accounting OfficerTax withholding · $26K · 318 sh	Tax withholding	318	$81.90	$26K	13,262	Form 4
Apr 28, 2026Form 4	ARNOLD CRAIGDirectorTax withholding · $17K · 207 sh	Tax withholding	207	$81.90	$17K	42,185	Form 4
Apr 28, 2026Form 4	HOGAN RANDALL JDirectorTax withholding · $17K · 207 sh	Tax withholding	207	$81.90	$17K	48,998	Form 4
Apr 28, 2026Form 4	DONNELLY SCOTT CDirectorTax withholding · $17K · 207 sh	Tax withholding	207	$81.90	$17K	23,679	Form 4
Apr 28, 2026Form 4	Powell Kendall JDirectorTax withholding · $17K · 207 sh	Tax withholding	207	$81.90	$17K	51,380	Form 4
Apr 28, 2026Form 4	Fonseca LidiaDirectorTax withholding · $17K · 207 sh	Tax withholding	207	$81.90	$17K	7,644	Form 4
Apr 28, 2026Form 4	Lofton Kevin EDirectorTax withholding · $17K · 207 sh	Tax withholding	207	$81.90	$17K	10,140	Form 4
Apr 28, 2026Form 4	NABEL ELIZABETH GDirectorTax withholding · $17K · 207 sh	Tax withholding	207	$81.90	$17K	19,584	Form 4
Apr 28, 2026Form 4	Lewis Gregory PDirectorTax withholding · $17K · 207 sh	Tax withholding	207	$81.90	$17K	5,754	Form 4
Apr 27, 2026Form 4	ARNOLD CRAIGDirectorAward · $0 · 2,111 sh	Award	2,111	$0.00	$0	42,392	Form 4
Apr 27, 2026Form 4	HOGAN RANDALL JDirectorAward · $0 · 2,111 sh	Award	2,111	$0.00	$0	49,205	Form 4
Apr 27, 2026Form 4	DONNELLY SCOTT CDirectorAward · $0 · 2,111 sh	Award	2,111	$0.00	$0	23,886	Form 4
Apr 27, 2026Form 4	Powell Kendall JDirectorAward · $0 · 2,111 sh	Award	2,111	$0.00	$0	51,587	Form 4
Apr 27, 2026Form 4	Fonseca LidiaDirectorAward · $0 · 2,111 sh	Award	2,111	$0.00	$0	7,851	Form 4
Apr 27, 2026Form 4	Lofton Kevin EDirectorAward · $0 · 2,111 sh	Award	2,111	$0.00	$0	10,347	Form 4
Apr 27, 2026Form 4	NABEL ELIZABETH GDirectorAward · $0 · 2,111 sh	Award	2,111	$0.00	$0	19,791	Form 4
Apr 27, 2026Form 4	Lewis Gregory PDirectorAward · $0 · 2,111 sh	Award	2,111	$0.00	$0	5,961	Form 4
Apr 27, 2026Form 4	Lee Joon SupDirectorAward · $0 · 1,803 sh	Award	1,803	$0.00	$0	1,803	Form 4
Apr 27, 2026Form 4	Blomquist Denise L.Chief Accounting OfficerAward · $0 · 1,508 sh	Award	1,508	$0.00	$0	13,580	Form 4
Apr 27, 2026Form 4	Jellison William RDirectorAward · $0 · 1,444 sh	Award	1,444	$0.00	$0	6,444	Form 4
Apr 27, 2026Form 4	Groetelaars John PDirectorAward · $0 · 1,444 sh	Award	1,444	$0.00	$0	1,444	Form 4
Mar 3, 2026Form 4	Pieton ThierryEVP & Chief Financial OfficerTax withholding · $288K · 2,976 sh	Tax withholding	2,976	$96.71	$288K	37,574	Form 4
Feb 20, 2026Form 4	Blomquist Denise L.Chief Accounting OfficerGift · $0 · 340 sh	Gift	340	$0.00	$0	11,966	Form 4
Feb 19, 2026Form 4	KIIL HARRY SKIPEVP & President CardiovascularExercise or conversion · $4.6M · 50,876 sh	Exercise or conversion	50,876	$80.00–$93.08	$4.6M	85,292	Form 4
Feb 19, 2026Form 4	KIIL HARRY SKIPEVP & President CardiovascularExercise or conversion · Stock Option (Right to Buy) · $0 · 50,876 sh	Exercise or conversion· Stock Option (Right to Buy)	50,876	$0.00	$0	1,155	Form 4
Jan 29, 2026Form 4	Blomquist Denise L.Chief Accounting OfficerTax withholding · $15K · 148 sh	Tax withholding	148	$101.00	$15K	12,306	Form 4

Reports and proxy statements#

Annual reports (10-K, 20-F, 40-F), quarterly reports (10-Q), current reports (8-K, 6-K) and proxy statements, newest first. An 8-K that furnishes a press release is headed by the release’s headline, its items beneath; any other 8-K is described by its items. A form opens the press release where there is one, else the document on EDGAR, or the filing’s index where it furnishes other exhibits.

2026 · 13 filings

Filed	Form	What it is	Period
Sep 17, 20268-K	8-K	Other events	Sep 17, 2026
Sep 3, 202610-Q	10-Q	Quarterly report, Q1 FY2027 — revenue $9.76B (+14% y/y), net income $1.47B, EPS $1.14	Jul 31, 2026
Sep 1, 20268-K	8-K	Earnings release — EPS $1.45 vs $1.39 est. (+4.3%); revenue $9.76B (+14% y/y) 1.5%	Sep 1, 2026
Aug 24, 2026ARS	ARS	Annual report to shareholders	Apr 24, 2026
Aug 17, 2026DEFA14A	DEFA14A	Additional proxy materials	—
Aug 17, 2026DEF 14A	DEF 14A	Proxy statement	Oct 15, 2026
Jun 18, 202610-K	10-K	Annual report, FY2026 — revenue $36.36B (+8% y/y), net income $4.80B, EPS $3.73	Apr 24, 2026
Jun 3, 20268-K	8-K	Earnings release — EPS $1.55 vs $1.54 est. (+0.7%); revenue $9.81B (+10% y/y) 5.7%	Jun 3, 2026
May 18, 20268-K	8-K	Directors or officers; compensation	May 18, 2026
Apr 27, 20268-K	8-K	Regulation FD disclosure	Apr 24, 2026
Mar 24, 20268-K	8-K	Regulation FD disclosure	Mar 24, 2026
Feb 24, 202610-Q	10-Q	Quarterly report, Q3 2026 — revenue $9.02B (+9% y/y), net income $1.14B, EPS $0.89	Jan 23, 2026
Feb 17, 20268-K	8-K	Earnings release — EPS $1.36 vs $1.33 est. (+2.3%); revenue $9.02B (+9% y/y) 3.1%	Feb 17, 2026

2025 · 19 filings

Filed	Form	What it is	Period
Nov 25, 202510-Q	10-Q	Quarterly report, Q2 FY2026 — revenue $8.96B (+7% y/y), net income $1.37B, EPS $1.07	Oct 24, 2025
Nov 18, 20258-K	8-K	Earnings release — EPS $1.36 vs $1.31 est. (+3.8%); revenue $8.96B (+7% y/y) 4.7%	Nov 18, 2025
Nov 3, 20258-K	8-K	Directors or officers; compensation	Nov 1, 2025
Oct 21, 20258-K	8-K	Charter, bylaws or fiscal-year change; Shareholder vote results	Oct 16, 2025
Sep 29, 20258-K	8-K	Material definitive agreement; Other events	Sep 29, 2025
Sep 16, 20258-K	8-K	Regulation FD disclosure; Other events	Sep 15, 2025
Sep 4, 2025ARS	ARS	Annual report to shareholders	Apr 25, 2025
Aug 26, 202510-Q	10-Q	Quarterly report, Q1 FY2026 — revenue $8.58B (+8% y/y), net income $1.04B, EPS $0.81	Jul 25, 2025
Aug 25, 2025DEFA14A	DEFA14A	Additional proxy materials	—
Aug 25, 2025DEF 14A	DEF 14A	Proxy statement	Oct 16, 2025
Aug 19, 20258-K	8-K	Earnings release — EPS $1.26 vs $1.23 est. (+2.4%); revenue $8.58B (+8% y/y) 3.1%	Aug 18, 2025
Aug 5, 2025PRE 14A	PRE 14A	Preliminary proxy statement	Oct 16, 2025
Jun 23, 20258-K	8-K	Directors or officers; compensation	Jun 18, 2025
Jun 20, 202510-K	10-K	Annual report, FY2025 — revenue $33.54B (+4% y/y), net income $4.66B, EPS $3.61	Apr 25, 2025
May 21, 20258-K	8-K	Results of operations; Directors or officers; compensation; Other events	May 21, 2025
Mar 17, 20258-K	8-K	Directors or officers; compensation	Mar 12, 2025
Feb 25, 202510-Q	10-Q	Quarterly report, Q3 2025 — revenue $8.29B (+3% y/y), net income $1.29B, EPS $1.01	Jan 24, 2025
Feb 18, 20258-K	8-K	Results of operations	Feb 18, 2025
Jan 21, 20258-K	8-K	Directors or officers; compensation	Jan 17, 2025

2024 · 16 filings

Filed	Form	What it is	Period
Nov 26, 202410-Q	10-Q	Quarterly report, Q2 FY2025 — revenue $8.40B (+5% y/y), net income $1.27B, EPS $0.99	Oct 25, 2024
Nov 19, 20248-K	8-K	Results of operations	Nov 19, 2024
Oct 21, 20248-K	8-K	Shareholder vote results	Oct 17, 2024
Sep 5, 2024ARS	ARS	Annual report to shareholders	Apr 26, 2024
Aug 27, 202410-Q	10-Q	Quarterly report, Q1 FY2025 — revenue $7.92B (+3% y/y), net income $1.04B, EPS $0.80	Jul 26, 2024
Aug 20, 20248-K	8-K	Results of operations	Aug 20, 2024
Aug 16, 20248-K/A	8-K/A	Directors or officers; compensation	Jun 21, 2024
Aug 9, 2024DEFA14A	DEFA14A	Additional proxy materials	—
Aug 9, 2024DEF 14A	DEF 14A	Proxy statement	Oct 17, 2024
Jun 26, 20248-K	8-K	Directors or officers; compensation; Regulation FD disclosure	Jun 21, 2024
Jun 20, 202410-K	10-K	Annual report, FY2024 — revenue $32.36B (+4% y/y), net income $3.68B, EPS $2.76	Apr 26, 2024
Jun 4, 20248-K	8-K	Directors or officers; compensation	Jun 1, 2024
Jun 3, 20248-K	8-K	Material definitive agreement; Regulation FD disclosure; Other events	Jun 3, 2024
May 23, 20248-K	8-K	Results of operations	May 23, 2024
Feb 27, 202410-Q	10-Q	Quarterly report, Q3 2024 — revenue $8.09B (+5% y/y), net income $1.32B, EPS $0.99	Jan 26, 2024
Feb 20, 20248-K	8-K	Results of operations; Directors or officers; compensation	Feb 13, 2024

2023 · 17 filings — 10 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms

Filed	Form	What it is	Period
Nov 30, 202310-Q	10-Q	Quarterly report, Q2 FY2024 — revenue $7.98B (+5% y/y), net income $909.0M, EPS $0.68	Oct 27, 2023
Sep 13, 2023ARS	ARS	Annual report to shareholders	Apr 28, 2023
Aug 31, 202310-Q	10-Q	Quarterly report, Q1 FY2024 — revenue $7.70B (+4% y/y), net income $791.0M, EPS $0.59	Jul 28, 2023
Aug 11, 2023DEFA14A	DEFA14A	Additional proxy materials	—
Aug 11, 2023DEF 14A	DEF 14A	Proxy statement	Oct 19, 2023
Jun 22, 202310-K	10-K	Annual report, FY2023 — revenue $31.23B (−1% y/y), net income $3.76B, EPS $2.82	Apr 28, 2023
Mar 1, 202310-Q	10-Q	Quarterly report, Q3 2023 — revenue $7.73B (−0% y/y), net income $1.22B, EPS $0.92	Jan 27, 2023

10 current reports (8-K) not listed; the year is on EDGAR.

2022 · 14 filings — 8 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms

Filed	Form	What it is	Period
Dec 1, 202210-Q	10-Q	Quarterly report, Q2 FY2023 — revenue $7.58B (−3% y/y), net income $427.0M, EPS $0.32	Oct 28, 2022
Sep 1, 202210-Q	10-Q	Quarterly report, Q1 FY2023 — revenue $7.37B (−8% y/y), net income $929.0M, EPS $0.70	Jul 29, 2022
Aug 19, 2022DEFA14A	DEFA14A	Additional proxy materials	—
Aug 19, 2022DEF 14A	DEF 14A	Proxy statement	Dec 8, 2022
Jun 23, 202210-K	10-K	Annual report, FY2022 — revenue $31.69B (+5% y/y), net income $5.04B, EPS $3.73	Apr 29, 2022
Mar 3, 202210-Q	10-Q	Quarterly report, Q3 2022 — revenue $7.76B (−0% y/y), net income $1.48B, EPS $1.10	Jan 28, 2022

8 current reports (8-K) not listed; the year is on EDGAR.

2021 · 22 filings — 12 × 8-K, 3 × 10-Q, 2 × DFAN14A and 5 other forms

Filed	Form	What it is	Period
Dec 2, 202110-Q	10-Q	Quarterly report, Q2 FY2022 — revenue $7.85B (+3% y/y), net income $1.31B, EPS $0.97	Oct 29, 2021
Oct 8, 2021DEFA14A	DEFA14A	Additional proxy materials	—
Oct 8, 2021DEFR14A	DEFR14A	Proxy statements	—
Sep 2, 202110-Q	10-Q	Quarterly report, Q1 FY2022 — revenue $7.99B (+23% y/y), net income $763.0M, EPS $0.56	Jul 30, 2021
Aug 27, 2021DEF 14A	DEF 14A	Proxy statement	Dec 9, 2021
Aug 6, 2021DFAN14A	DFAN14A	Proxy statements	—
Aug 6, 2021DFAN14A	DFAN14A	Proxy statements	—
Jun 25, 202110-K	10-K	Annual report, FY2021 — revenue $30.12B (+4% y/y), net income $3.61B, EPS $2.66	Apr 30, 2021
Mar 5, 202110-Q	10-Q	Quarterly report, Q3 2021 — revenue $7.78B (+1% y/y), net income $1.27B, EPS $0.94	Jan 29, 2021

13 current reports (8-K) not listed; the year is on EDGAR.

2020 · 19 filings — 12 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms

Filed	Form	What it is	Period
Dec 3, 202010-Q	10-Q	Quarterly report, Q2 FY2021 — revenue $7.65B (−1% y/y), net income $489.0M, EPS $0.36	Oct 30, 2020
Oct 13, 2020DEFA14A	DEFA14A	Additional proxy materials	—
Oct 13, 2020DEFR14A	DEFR14A	Proxy statements	—
Sep 3, 202010-Q	10-Q	Quarterly report, Q1 FY2021 — revenue $6.51B (−13% y/y), net income $487.0M, EPS $0.36	Jul 31, 2020
Aug 14, 2020DEF 14A	DEF 14A	Proxy statement	Dec 11, 2020
Jun 19, 202010-K	10-K	Annual report, FY2020 — revenue $28.91B (−5% y/y), net income $4.79B, EPS $3.54	Apr 24, 2020
Feb 28, 202010-Q	10-Q	Quarterly report, Q3 2020 — revenue $7.72B (+2% y/y), net income $1.92B, EPS $1.42	Jan 24, 2020

12 current reports (8-K) not listed; the year is on EDGAR.

2019 · 23 filings — 16 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms

Filed	Form	What it is	Period
Dec 3, 201910-Q	10-Q	Quarterly report, Q2 FY2020 — revenue $7.71B (+3% y/y), net income $1.36B, EPS $1.01	Oct 25, 2019
Oct 24, 2019DEFA14A	DEFA14A	Additional proxy materials	—
Sep 30, 2019DEFR14A	DEFR14A	MEDTRONIC PLC - DEFR14A	—
Aug 30, 201910-Q	10-Q	Quarterly report, Q1 FY2020 — revenue $7.49B (+1% y/y), net income $864.0M, EPS $0.64	Jul 26, 2019
Aug 16, 2019DEF 14A	DEF 14A	Proxy statement	Dec 6, 2019
Jun 21, 201910-K	10-K	Annual report, FY2019 — revenue $30.56B (+2% y/y), net income $4.63B, EPS $3.41	Apr 26, 2019
Mar 1, 201910-Q	10-Q	Quarterly report, Q3 2019 — revenue $7.55B (+2% y/y), net income $1.27B, EPS $0.94	Jan 25, 2019

16 current reports (8-K) not listed; the year is on EDGAR.

2018 · 15 filings — 9 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms

Filed	Form	What it is	Period
Nov 29, 201810-Q	10-Q	Quarterly report, Q2 FY2019 — revenue $7.48B (+6% y/y), net income $1.11B, EPS $0.82	Oct 26, 2018
Oct 23, 2018DEFA14A	DEFA14A	Additional proxy materials	—
Aug 31, 201810-Q	10-Q	Quarterly report, Q1 FY2019 — revenue $7.38B (−0% y/y), net income $1.07B, EPS $0.79	Jul 27, 2018
Aug 24, 2018DEF 14A	DEF 14A	Proxy statement	Aug 24, 2018
Jun 22, 201810-K	10-K	Annual report, FY2018 — revenue $29.95B (+1% y/y), net income $3.10B, EPS $2.27	Apr 27, 2018
Mar 2, 201810-Q	10-Q	Quarterly report, Q3 2018 — revenue $7.37B (+1% y/y), net income −$1.39B, EPS −$1.03	Jan 26, 2018

9 current reports (8-K) not listed; the year is on EDGAR.

2017 · 18 filings — 11 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms

Filed	Form	What it is	Period
Dec 4, 201710-Q	10-Q	Quarterly report, Q2 FY2018 — revenue $7.05B (−4% y/y), net income $2.02B, EPS $1.48	Oct 27, 2017
Oct 24, 2017DEFA14A	DEFA14A	Additional proxy materials	—
Oct 11, 2017DEFR14A	DEFR14A	MEDTRONIC PLC - DEFR14A	—
Sep 1, 201710-Q	10-Q	Quarterly report, Q1 FY2018 — revenue $7.39B (+3% y/y), net income $1.02B, EPS $0.74	Jul 28, 2017
Aug 28, 2017DEF 14A	DEF 14A	Proxy statement	Aug 28, 2017
Jun 27, 201710-K	10-K	Annual report, FY2017 — revenue $29.71B (+3% y/y), net income $4.03B, EPS $2.89	Apr 28, 2017
Mar 3, 201710-Q	10-Q	Quarterly report, Q3 2017 — revenue $7.28B (+5% y/y), net income $821.0M, EPS $0.59	Jan 27, 2017

11 current reports (8-K) not listed; the year is on EDGAR.

2016 · 22 filings — 13 × 8-K, 3 × 10-Q, 2 × DEFA14A and 4 other forms

Counted, not listed; the year is on EDGAR.

2015 · 33 filings — 21 × 8-K, 4 × 10-Q, 2 × 8-K/A and 4 other forms

Counted, not listed; the year is on EDGAR.

2014 · 36 filings — 25 × 8-K, 3 × 10-Q, 3 × DEFA14A and 5 other forms

Counted, not listed; the year is on EDGAR.

2013 · 20 filings — 11 × 8-K, 3 × 10-Q, 2 × DEFA14A and 4 other forms

Counted, not listed; the year is on EDGAR.

2012 · 22 filings — 14 × 8-K, 3 × 10-Q, 1 × 10-K and 4 other forms

Counted, not listed; the year is on EDGAR.

2011 · 19 filings — 10 × 8-K, 3 × 10-Q, 2 × 10-Q/A and 4 other forms

Counted, not listed; the year is on EDGAR.

2010 · 21 filings — 10 × 8-K, 3 × 10-Q, 3 × DFAN14A and 5 other forms

Counted, not listed; the year is on EDGAR.

2009 · 16 filings — 8 × 8-K, 3 × 10-Q, 1 × 10-K and 4 other forms

Counted, not listed; the year is on EDGAR.

2008 · 18 filings — 9 × 8-K, 3 × 10-Q, 1 × 10-K and 5 other forms

Counted, not listed; the year is on EDGAR.

2007 · 29 filings — 16 × 8-K, 5 × DFAN14A, 3 × 10-Q and 5 other forms

Counted, not listed; the year is on EDGAR.

2006 · 21 filings — 15 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms

Counted, not listed; the year is on EDGAR.

2005 · 18 filings — 12 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms

Counted, not listed; the year is on EDGAR.

2004 · 14 filings — 9 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form

Counted, not listed; the year is on EDGAR.

2003 · 11 filings — 6 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form

Counted, not listed; the year is on EDGAR.

2002 · 18 filings — 11 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms

Counted, not listed; the year is on EDGAR.

2001 · 9 filings — 3 × 10-Q, 2 × 8-K, 1 × 10-K and 3 other forms

Counted, not listed; the year is on EDGAR.

2000 · 9 filings — 3 × 10-Q, 3 × 8-K, 1 × 10-K and 2 other forms

Counted, not listed; the year is on EDGAR.

1999 · 17 filings — 9 × 8-K, 3 × 10-Q, 2 × 10-K/A and 3 other forms

Counted, not listed; the year is on EDGAR.

1998 · 18 filings — 11 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms

Counted, not listed; the year is on EDGAR.

1997 · 7 filings — 3 × 10-Q, 1 × 10-K/A, 1 × 10-K405 and 2 other forms

Counted, not listed; the year is on EDGAR.

1996 · 13 filings — 6 × 8-K, 3 × 10-Q, 2 × 10-K/A and 2 other forms

Counted, not listed; the year is on EDGAR.

1995 · 7 filings — 3 × 10-Q, 1 × 10-K, 1 × 10-K/A and 2 other forms

Counted, not listed; the year is on EDGAR.

1994 · 6 filings — 3 × 10-Q, 1 × 10-K, 1 × 10-K/A and 1 other form

Counted, not listed; the year is on EDGAR.

Insider, ownership and other filings#

Insider ownership (Forms 3, 4, 5 and 144), beneficial ownership (Schedules 13D and 13G), registration and prospectus (S-1, S-3, S-8, 424B and related) and the rest, counted by year, with the newest 25 of each of the latest 3 years shown. A Form 4 is one insider’s transaction report; a 13G is a passive holder above five percent.

2026 · 95 filings — 42 × 4, 36 × 425, 4 × 144 and 8 other forms

Filed	Form	What it is	Period
Oct 7, 2026425	425	Merger communication	—
Oct 6, 2026425	425	Merger communication	—
Oct 5, 2026425	425	Merger communication	—
Oct 2, 2026425	425	Merger communication	—
Oct 1, 2026425	425	Merger communication	—
Sep 30, 2026425	425	Merger communication	—
Sep 29, 2026425	425	Merger communication	—
Sep 28, 2026425	425	Merger communication	—
Sep 25, 2026425	425	Merger communication	—
Sep 25, 2026425	425	Merger communication	—
Sep 24, 2026425	425	Merger communication	—
Sep 23, 2026425	425	Merger communication	—
Sep 22, 2026425	425	Merger communication	—
Sep 21, 2026425	425	Merger communication	—
Sep 21, 2026425	425	Merger communication	—
Sep 21, 2026425	425	Merger communication	—
Sep 18, 2026425	425	Merger communication	—
Sep 17, 2026425	425	Merger communication	—
Sep 17, 2026SC TO-I/A	SC TO-I/A	Beneficial ownership	—
Sep 17, 2026425	425	Merger communication	—
Sep 17, 20264	4	Insider transaction (Form 4)	Sep 16, 2026
Sep 16, 2026425	425	Merger communication	—
Sep 16, 2026425	425	Merger communication	—
Sep 16, 20264	4	Insider transaction (Form 4)	Sep 15, 2026
Sep 16, 2026144	144	Notice of proposed sale (Form 144)	—

The newest 25 of 95 shown; the full year is on EDGAR.

2025 · 75 filings — 46 × 4, 7 × 3, 5 × 144 and 9 other forms

Filed	Form	What it is	Period
Dec 17, 20254	4	Insider transaction (Form 4)	Dec 15, 2025
Dec 17, 20254	4	Insider transaction (Form 4)	Dec 15, 2025
Dec 17, 20254	4	Insider transaction (Form 4)	Dec 15, 2025
Dec 9, 20254	4	Insider transaction (Form 4)	Dec 5, 2025
Dec 3, 2025SCHEDULE 13G/A	SCHEDULE 13G/A	Other filings	—
Nov 25, 2025IRANNOTICE	IRANNOTICE	Other filings	—
Nov 24, 20254	4	Insider transaction (Form 4)	Nov 20, 2025
Nov 21, 20254	4	Insider transaction (Form 4)	Nov 19, 2025
Nov 19, 2025144	144	Notice of proposed sale (Form 144)	—
Oct 24, 202511-K/A	11-K/A	Employee plan annual report, amended	Apr 30, 2025
Oct 24, 202511-K/A	11-K/A	Employee plan annual report, amended	Apr 30, 2025
Oct 20, 202511-K	11-K	Employee plan annual report	Apr 30, 2025
Oct 20, 202511-K	11-K	Employee plan annual report	Apr 30, 2025
Oct 15, 202525-NSE	25-NSE	Delisting notice from the exchange	—
Sep 29, 202525-NSE	25-NSE	Delisting notice from the exchange	—
Sep 29, 2025CERT	CERT	NYSE CERTIFICATION	—
Sep 15, 2025FWP	FWP	Free writing prospectus	—
Sep 5, 20254	4	Insider transaction (Form 4)	Sep 3, 2025
Sep 3, 2025144	144	Notice of proposed sale (Form 144)	—
Aug 26, 2025IRANNOTICE	IRANNOTICE	Other filings	—
Aug 25, 20254	4	Insider transaction (Form 4)	Aug 22, 2025
Aug 21, 20254	4	Insider transaction (Form 4)	Aug 20, 2025
Aug 19, 20253	3	Initial insider holdings (Form 3)	Aug 19, 2025
Aug 19, 20253	3	Initial insider holdings (Form 3)	Aug 19, 2025
Aug 4, 20254	4	Insider transaction (Form 4)	Aug 1, 2025

The newest 25 of 75 shown; the full year is on EDGAR.

2024 · 78 filings — 52 × 4, 10 × 144, 3 × SC 13G/A and 9 other forms

Filed	Form	What it is	Period
Dec 17, 20244	4	Insider transaction (Form 4)	Dec 16, 2024
Dec 17, 20244	4	Insider transaction (Form 4)	Dec 16, 2024
Dec 17, 20244	4	Insider transaction (Form 4)	Dec 16, 2024
Dec 17, 20244	4	Insider transaction (Form 4)	Dec 16, 2024
Dec 11, 20244	4	Insider transaction (Form 4)	Dec 10, 2024
Dec 10, 20244	4	Insider transaction (Form 4)	Dec 6, 2024
Dec 9, 20244	4	Insider transaction (Form 4)	Dec 6, 2024
Nov 21, 2024UPLOAD	UPLOAD	Letter from the SEC staff	—
Nov 18, 2024CORRESP	CORRESP	Letter to the SEC	—
Nov 13, 2024UPLOAD	UPLOAD	Letter from the SEC staff	—
Oct 31, 2024144	144	Notice of proposed sale (Form 144)	—
Oct 30, 2024144	144	Notice of proposed sale (Form 144)	—
Oct 29, 2024144	144	Notice of proposed sale (Form 144)	—
Oct 24, 202411-K	11-K	Employee plan annual report	Apr 30, 2024
Oct 24, 202411-K	11-K	Employee plan annual report	Apr 30, 2024
Oct 24, 2024144	144	Notice of proposed sale (Form 144)	—
Oct 23, 2024144	144	Notice of proposed sale (Form 144)	—
Oct 18, 2024144	144	Notice of proposed sale (Form 144)	—
Oct 17, 2024144	144	Notice of proposed sale (Form 144)	—
Aug 27, 2024IRANNOTICE	IRANNOTICE	Other filings	—
Aug 26, 2024144	144	Notice of proposed sale (Form 144)	—
Aug 21, 20244	4	Insider transaction (Form 4)	Aug 20, 2024
Aug 19, 20244	4	Insider transaction (Form 4)	Aug 15, 2024
Aug 12, 20243	3	Initial insider holdings (Form 3)	Aug 3, 2024
Aug 6, 20244	4	Insider transaction (Form 4)	Aug 2, 2024

The newest 25 of 78 shown; the full year is on EDGAR.

2023 · 65 filings — 43 × 4, 6 × 144, 3 × 3 and 8 other forms

Counted, not listed; the year is on EDGAR.

2022 · 52 filings — 37 × 4, 3 × 3, 3 × IRANNOTICE and 7 other forms

Counted, not listed; the year is on EDGAR.

2021 · 72 filings — 57 × 4, 3 × IRANNOTICE, 3 × SC 13G/A and 7 other forms

Counted, not listed; the year is on EDGAR.

2020 · 90 filings — 79 × 4, 3 × SC 13G/A, 2 × 11-K and 6 other forms

Counted, not listed; the year is on EDGAR.

2019 · 87 filings — 62 × 4, 10 × 4/A, 3 × 3 and 6 other forms

Counted, not listed; the year is on EDGAR.

2018 · 62 filings — 53 × 4, 3 × SC 13G/A, 2 × 11-K and 4 other forms

Counted, not listed; the year is on EDGAR.

2017 · 76 filings — 59 × 4, 6 × SC 13G/A, 2 × 11-K and 7 other forms

Counted, not listed; the year is on EDGAR.

2016 · 96 filings — 68 × 4, 7 × SC 13G, 4 × SC TO-T/A and 9 other forms

Counted, not listed; the year is on EDGAR.

2015 · 163 filings — 88 × 4, 23 × 3, 18 × 425 and 11 other forms

Counted, not listed; the year is on EDGAR.

2014 · 223 filings — 146 × 425, 54 × 4, 4 × 3 and 10 other forms

Counted, not listed; the year is on EDGAR.

2013 · 66 filings — 47 × 4, 3 × 3, 3 × SC 13D/A and 9 other forms

Counted, not listed; the year is on EDGAR.

2012 · 49 filings — 36 × 4, 3 × 3, 2 × 11-K and 7 other forms

Counted, not listed; the year is on EDGAR.

2011 · 60 filings — 38 × 4, 5 × 4/A, 4 × UPLOAD and 8 other forms

Counted, not listed; the year is on EDGAR.

2010 · 57 filings — 45 × 4, 2 × 11-K, 2 × NO ACT and 8 other forms

Counted, not listed; the year is on EDGAR.

2009 · 68 filings — 55 × 4, 2 × 11-K, 2 × 3 and 7 other forms

Counted, not listed; the year is on EDGAR.

2008 · 116 filings — 95 × 4, 5 × 3, 3 × 4/A and 7 other forms

Counted, not listed; the year is on EDGAR.

2007 · 121 filings — 100 × 4, 5 × 3, 4 × 424B7 and 8 other forms

Counted, not listed; the year is on EDGAR.

2006 · 108 filings — 84 × 4, 6 × 424B7, 3 × CORRESP and 9 other forms

Counted, not listed; the year is on EDGAR.

2005 · 122 filings — 88 × 4, 7 × 4/A, 3 × 3 and 16 other forms

Counted, not listed; the year is on EDGAR.

2004 · 110 filings — 78 × 4, 13 × 4/A, 5 × 3 and 11 other forms

Counted, not listed; the year is on EDGAR.

2003 · 109 filings — 84 × 4, 9 × 4/A, 4 × 11-K and 8 other forms

Counted, not listed; the year is on EDGAR.

2002 · 139 filings — 55 × 4, 25 × 424B3, 22 × 5 and 12 other forms

Counted, not listed; the year is on EDGAR.

2001 · 13 filings — 4 × 4, 2 × S-8, 2 × SC 13D and 3 other forms

Counted, not listed; the year is on EDGAR.

2000 · 15 filings — 6 × 425, 2 × S-8, 2 × SC 13G/A and 5 other forms

Counted, not listed; the year is on EDGAR.

1999 · 10 filings — 5 × S-8, 1 × S-4, 1 × S-4/A and 3 other forms

Counted, not listed; the year is on EDGAR.

1998 · 23 filings — 5 × SC 13D, 4 × S-4, 3 × S-4/A and 8 other forms

Counted, not listed; the year is on EDGAR.

1997 · 5 filings — 4 × SC 13G, 1 × SC 13D

Counted, not listed; the year is on EDGAR.

1996 · 12 filings — 3 × S-3, 3 × SC 13G, 2 × 424B3 and 3 other forms

Counted, not listed; the year is on EDGAR.

1995 · 4 filings — 2 × S-3, 2 × S-8

Counted, not listed; the year is on EDGAR.

1994 · 3 filings — 1 × S-4, 1 × S-4/A, 1 × S-8

Counted, not listed; the year is on EDGAR.

About this data#

Medtronic plc. (MDT) has 3,024 filings on EDGAR going back to 1994: 43 annual reports, 104 quarterly reports and 332 current reports, plus proxy statements, insider forms and ownership schedules. Its latest annual report, a 10-K, was filed on Jun 18, 2026 for the fiscal year ended Apr 24, 2026. The most recent 8-K, on Sep 17, 2026, covered other events. Over the last 13 months insiders sold $5.9M in 4 sales and bought nothing on the open market; 77 other transactions (awards, exercises, tax withholding, gifts and plan purchases). Not investment advice.

Every row is a filing EDGAR lists for the registrants that have been Medtronic plc., read from the SEC’s submissions index each morning; a filing accepted after that read appears the next day. Where a company changed its filing entity (a holding-company reorganisation, Google into Alphabet) the predecessor’s filings are shown for the years it filed as the company, derived from the filings themselves. Dates are the filing date; the period is the report’s own. The latest 3 years of reports are listed in full, the next years to 10 without their 8-Ks, and older years are counted; the other forms are counted too, with the newest 25 of each of the latest 3 years shown. Insider transactions are the Form 4 and Form 5 documents themselves, filed since January 2026, every number as the insider filed it: a day’s lots are summed, a blank price adds its shares and no dollars, and a purchase through an employee stock plan is a plan purchase, not insider buying. An 8-K’s headline is the first line of the press release it furnishes (Exhibit 99), read from the filing and shown word for word; where two independent readings of the exhibit do not agree, the 8-K is described by its items instead. The documents stay on sec.gov, public domain, and every link opens the SEC’s copy. ChartRow does not summarise or interpret filings.

FAQ#

Where can I read MDT's latest 10-K?: MDT's latest annual report, a 10-K, was filed on Jun 18, 2026 for the fiscal year ended Apr 24, 2026. It is linked above and opens on EDGAR, the SEC's own site, where every exhibit is also listed.
When did MDT last file an 8-K?: On Sep 17, 2026 it covered other events. An 8-K reports a material event between quarterly reports; the one that furnishes the quarter's results is filed under Item 2.02, last on Sep 1, 2026.
Are MDT insiders buying or selling?: Over the last 13 months insiders sold $5.9M in 4 sales and bought nothing on the open market; 77 other transactions (awards, exercises, tax withholding, gifts and plan purchases). The most recent sale: KIIL HARRY SKIP (EVP & President Cardiovascular) sold 1,483 shares on Sep 16, 2026 for $139K. Every figure is as the insider filed it on Form 4; a sale under a 10b5-1 plan was scheduled in advance.
How many SEC filings has MDT made?: 3,024 filings are on EDGAR under the registrant records that have been Medtronic plc., going back to 1994; 1,780 of them are insider ownership forms (Forms 3, 4, 5 and 144).

MDT SEC filings (2026)

What happened, last 12 months#

September 2026

August 2026

July 2026

June 2026

May 2026

April 2026

March 2026

February 2026

November 2025

October 2025

Insider transactions#

Reports and proxy statements#

Insider, ownership and other filings#

About this data#

FAQ#